MedTrace Logo

Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704)

NCT03992352 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1229

Last updated 2024-02-06

No results posted yet for this study

Summary

Prospective observational multicenter study of allogeneic Hematopoietic Stem Cell Transplantation (HCT) in recipients 60 years and older to assess important determinants of health status to be combined into a composite health risk model to improve risk assessment of non-relapse mortality (NRM).

Conditions

  • Hematologic Malignancy

Interventions

DIAGNOSTIC_TEST

Age 60+ with planned HCT for Hematologic Malignancy

questionnaires, geriatric assessments

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • National Cancer Institute (NCI)

    collaborator NIH

  • Blood and Marrow Transplant Clinical Trials Network

    collaborator NETWORK

  • National Marrow Donor Program

    collaborator OTHER

  • Center for International Blood and Marrow Transplant Research

    lead NETWORK

Principal Investigators

  • Andrew Artz, MD, MS · City of Hope Medical Center

  • Mohamed Sorror, MD, MSc · Fred Hutchinson Cancer Center

  • Wael Saber, MD, MS · Medical College of Wisconsin/CIBMTR

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-19
Primary Completion
2023-05-29
Completion
2023-05-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03992352 on ClinicalTrials.gov